Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Being investigated for its role in cellular activity and maintenance
Peptide Vials (GHK-Cu, 50 mg each): 5 days/week (1.02.0 mg/day): 8 weeks (~50 mg total) 1 vial 12 weeks (~90 mg total) 2 vials 16 weeks (~130 mg total) 3 vials 3/week (2 mg each): 8 weeks (~48 mg) 1 vial 12 weeks (~72 mg) 2 vials 16 weeks (~96 mg) 2 vials Insulin Syringes (U100, 2931 gauge): 5 days/week: Per week: 5 syringes 8 weeks: 40 syringes 12 weeks: 60 syringes 16 weeks: 80 syringes 3/week: Per week: 3 syringes 8 weeks: 24 syringes 12 weeks: 36 syringes 16 weeks: 48 syringes Sterile or Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution
Sustained Results: Semaglutide led to reductions in body weight of up to 15.8% after 68 weeks of treatment (2.5mg)
Researchers are investigating its role in preventing progression of prediabetes, improving liver function in nonalcoholic fatty liver disease (NAFLD), and addressing broader metabolic syndromes
Just be aware that the clock started ticking the day the pharmacy made it, not the day you received it
Every batch of GHRP-2 undergoes independent third-party testing, with a Certificate of Analysis available per lot before purchase
US$ 29.13
US$ 27.26
US$ 29.88
US$ 20.72
US$ 25.07
